Trial Profile
Biomarker study of zoledronic acid and taxane-based chemotherapy in breast cancer patients with bone metastases
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 23 Oct 2014
Price :
$35
*
At a glance
- Drugs Zoledronic acid (Primary) ; Docetaxel; Paclitaxel
- Indications Advanced breast cancer; Bone metastases
- Focus Pharmacodynamics; Therapeutic Use
- Acronyms BEAT-ZO
- 23 Oct 2014 New trial record